ArticleFrontiers in artificial intelligence2026
Heart disease prediction using rough neutrosophic sets and dual-attention neural networks: RNS-OptiDANet.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Heart disease is a major global health problem that highlights the need for effective and accurate prediction methods. Methods: This paper presents RNS-OptiDANet, a hybrid framework that combines rough set theory (RST), rough neutrosophic sets (RNS) and an optimized dual-attention neural network (OptiDANet) in order to predict heart disease. For feature selection, the QuickReduct method with the discernibility matrix (RST QRDM) was used. The features selected in RST were represented as RNS representations to deal with uncertainty in the classification process. The OptiDANet model implements Dual Attention Mechanisms such as Channel Attention (CAM) and Soft Attention Mechanism (SAM) to highlight the relevant patterns while reducing noise. The performance of the developed framework has been improved through Hyperparameter tuning using Optuna and overfitting has been avoided. Finally, classification is conducted using a Random Forest (RF) model. Results: Experimental results demonstrate strong performance in terms of accuracy, precision, recall and F1-score across datasets. Discussion: An eXplainable Artificial Intelligence (XAI) module is integrated to provide feature level interpretability and clinical transparency while ablation study validates the contribution of each framework component confirming the robustness and effectiveness of the proposed hybrid RNS-OptiDANet model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.